CLEVELAND, June 9 /PRNewswire/ -- ChanTest, the leading provider of ion channel testing services for drug-discovery and development applications, has launched a completely redesigned Web site at http://www.ChanTest.com.
According to Dr. Arthur Brown, founder and CEO of ChanTest, the company's goal was to make the site more accessible to visitors, while providing significant improvements in content, navigation, and visual appeal. "The Internet is an important part of our strategy to meet the needs of the drug discovery and development community," said Dr. Brown. "For example, our 'Ask a Scientist' feature makes it easy, at a click of a button, to consult a ChanTest ion channel expert. We also take seriously our commitment to be a resource for members of the press and others who may be interested in learning more about the importance of ion channels in drug safety. An explanation of the cardiac safety issue can be found under 'Technology & Applications' from the main menu."
The new design structure makes it easier for users to find Web content. For example, many of the more than 300 articles by ChanTest scientists that have appeared in peer-reviewed journals can be downloaded easily by clicking on the article title. This comprehensive list of ChanTest articles can be found on the "Publications" page, accessible from "Technology & Applications" on the main menu. The site also features an extensive search function, scrolling headlines highlighting what's new, and listings of upcoming conferences and events.
The preeminent ion channel services company, ChanTest serves its drug
discovery and development customers with GLP safety and automated screening
assays using its library of ion channel-expressing cell lines - the most
comprehensive in the world. Since its inception in 1998, ChanTest has
tested more than 12,000 compounds for more than 250 global pharmaceutical
Copyright©2008 PR Newswire.
All rights reserved